High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitors

被引：10

作者：

Kenet, G ^{[1
]}

机构：

[1] Chaim Sheba Med Ctr, Israeli Natl Hemophilia Ctr, IL-52621 Tel Hashomer, Israel

来源：

SEMINARS IN HEMATOLOGY | 2006年 / 43卷 / 01期

关键词：

D O I：

10.1053/j.seminhematol.2005.11.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S108 / S110

页数：3

相关论文

共 29 条

[1] Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors [J].

Abshire, T ;

Kenet, G .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (06) :899-909

[2] Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: Improved efficacy with higher dosing [J].

Abshire, TC .

SEMINARS IN HEMATOLOGY, 2004, 41 (01) :3-7

[3]

Carr Marcus E Jr, 2004, Clin Lab, V50, P539

[4]

Carr ME, 2003, THROMB HAEMOSTASIS, V89, P803

[5] Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures [J].

Cooper, HA ;

Jones, CP ;

Campion, E ;

Roberts, HR ;

Hedner, U .

HAEMOPHILIA, 2001, 7 (05) :517-522

[6] Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision [J].

Dargaud, Y ;

Lienhart, A ;

Meunier, S ;

Hequet, O ;

Chavanne, H ;

Chamouard, V ;

Marin, S ;

Negrier, C .

HAEMOPHILIA, 2005, 11 (05) :552-558

[7] Pharmacokinetics of recombinant activated factor VII (rFVIIa) [J].

Erhardtsen, E .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :385-391

[8] The effect of recombinant factor VIIa (NovoSeven™) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0 [J].

Erhardtsen, E ;

Nony, P ;

Dechavanne, M ;

Ffrench, P ;

Boissel, JP ;

Hedner, U .

BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (08) :741-748

[9] Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor [J].

Hayashi, T ;

Tanaka, I ;

Shima, M ;

Yoshida, K ;

Fukuda, K ;

Sakurai, Y ;

Matsumoto, T ;

Giddings, JC ;

Yoshioka, A .

HAEMOPHILIA, 2004, 10 (04) :397-400

[10] The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia [J].

He, S ;

Ekman, GJ ;

Hedner, U .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) :272-279